Pricing Log in Create free account

BioAge Labs, Inc. (BIOA) vs Glass House Brands Inc. (GLAS)

BioAge Labs, Inc. and Glass House Brands Inc. are both Drug Manufacturers Specialty & Generic companies. BioAge Labs, Inc. is the larger, with a market value of $254.3M against $172.7M — 1.5× the size. Glass House Brands Inc. has the higher net margin (−36.2% vs −1,253.6%) and the lower return on invested capital (−23.4% vs −21.8%). Across the 16 metrics below, BioAge Labs, Inc. leads on 8 and Glass House Brands Inc. on 8.

Valuation

Metric BIOA GLAS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 29.58 1.14 2.08
P/B 0.73 2.79 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 0.52 n/m 12.22
EV/Sales (7.23) 1.35 2.87
Earnings yield (46.03%) (33.33%) (15.94%)
Free cash flow yield (101.34%) (18.18%) 0.00%

Profitability

Metric BIOA GLAS Drug Manufacturers Specialty & Generic median
Gross margin 100.00% 31.97% 53.51%
Operating margin (1,401.81%) (23.18%) 0.00%
Net margin (1,253.60%) (36.19%) (2.45%)
Free cash flow margin (2,997.41%) (20.78%) 0.00%
Return on equity (34.56%) (74.02%) (0.80%)
Return on assets (32.05%) (19.78%) (1.67%)
Return on invested capital (21.75%) (23.36%) 0.00%

Growth

Metric BIOA GLAS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (15.38%) 5.22%
EPS growth (last fiscal year) 66.21% (161.90%) 42.91%
Revenue growth, 5-year CAGR — — 7.24%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric BIOA GLAS Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.77 0.04
Current ratio 15.51 1.33 2.41
Net debt to EBITDA 3.01 (64.84) 1.01

Dividend

Metric BIOA GLAS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric BIOA GLAS Drug Manufacturers Specialty & Generic median
Market cap 254.27m 172.67m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack